Lukas Hartl - Concepedia

Author

Lukas Hartl

Medical University of Vienna ORCID

Also Known As

L Hartl, L. Hartl, Lisa Hartl, Lukas Hartl

234

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna CeMM Research Center for Molecular Medicine Austrian Academy of Sciences Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases Medizinische Hochschule Hannover

About

Lukas Hartl is an author at Medical University of Vienna specializing in medicine, virology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	86
2	Epidemiology	2	2	50
3	Public Health	1	1	17
4	Global Health	1	1	17
5	Hepatology	1	1	17

Lukas Hartl

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality Dalila Costa, Benedikt Simbrunner, Mathias Jachs, Journal of Hepatology	2020	186
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis Benedikt Hofer, Benedikt Simbrunner, Lukas Hartl, Clinical Gastroenterology and Hepatology	2022	108
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes Mathias Jachs, Lukas Hartl, Dunja Schaufler, Gut	2020	95
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease Georg Semmler, Zhenwei Yang, L. Fritz, Gastroenterology	2023	82
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event Lorenz Balcar, Marta Tonon, Georg Semmler, JHEP Reports	2022	76
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, Clinical Gastroenterology and Hepatology	2022	73
Hepatic recompensation according to Baveno <scp>VII</scp> criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis Benedikt Hofer, Benedikt Simbrunner, Lukas Hartl, Liver International	2023	73
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease Lukas Hartl, Katharina Haslinger, Martin Angerer, Hepatology	2022	72
Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study Mathias Jachs, Caroline Schwarz, Marlene Panzer, Alimentary Pharmacology & Therapeutics	2022	70
Safety of direct oral anticoagulants in patients with advanced liver disease Georg Semmler, Katharina Pomej, David Bauer, Liver International	2021	55

Page 1